IPO
LOGIN
OPEN A DEMAT ACCOUNT
IPO
Login
Open a
Demat
Account
HOME
ABOUT US
PRODUCTS
Equity
Currency
Commodity
IPO
Mutual Funds
PMS
SLBM
SERVICES
Investment Banking
Institutional Equities
Wealth Management
Depository
TRADE WITH SYSTEMATIX
Partner With Us
Trading Simplified
Payment Gateway
Link UPI
KYC Updation
ReKYC
(Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
Bank Details
Account Opening Process
RESEARCH
MARKETS
Overview
Equity
Derivatives
IPO
Mutual Funds
Commodity
Currency
Company Info
INVESTORS
Investor Login
Investor Relations
Investor Grievances
ODR
Scores
Downloads
Investor Charter
Information to Physical Shareholders
Procedure for Filing a Complaint
Investor Education
CONTACT US
Our Reach
Careers
OPEN A DEMAT ACCOUNT
HOME
ABOUT US
PRODUCTS
EQUITY
CURRENCY
COMMODITY
IPO
MUTUAL FUND
PMS
SLBM
SERVICES
INVESTMENT BANKING
INSTITUTIONAL EQUITIES
WEALTH MANAGEMENT
DEPOSITORY
TRADE WITH SYSTEMATIX
PARTNER WITH US
TRADING SIMPLIFIED
PAYMENT GATEWAY
LINK UPI
KYC UPDATION
ReKYC (Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
BANK DETAILS
ACCOUNT OPENING PROCESS
RESEARCH
MARKETS
OVERVIEW
EQUITY
DERIVATIVES
IPO
MUTUAL FUND
COMMODITY
CURRENCY
COMPANY INFO
INVESTORS
INVESTOR LOGIN
INVESTOR RELATIONS
INVESTOR GRIEVANCES
ODR
SCORES
DOWNLOADS
INVESTOR CHARTER
INFORMATION TO PHYSICAL SHAREHOLDERS
PROCEDURE FOR FILING A COMPLAINT
Investor Education
CONTACT US
OUR REACH
CAREERS
Equity
Derivatives
Currency
Mutual Fund
IPO Analysis
Daily Market Tracker
Gainers & Losers
Value & Volume Toppers
52 Week Highs & Lows
New Highs & Lows
Buyers & Sellers
Out/Under Performers
Bulk Deals
Block Deals
Unusual Volume
Rising Volume
Exchange Holidays
5 Days Up & Down
Index Movers
Index Overview
Top Sectors
News & Analysis
Pre Session Commentary
Mid Session Commentary
End Session Commentary
Quick Review
Market Beat
Stock Alert
Hot Pursuit
Foreign Markets
Economy News
Corporate News
Corporate Results
Other Markets
Futures Markets
Corporate Information
Company Snapshot
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Previous Quarter Comp
Director's Report
Score Board
Mutual Fund Holdings
Announcements
Peer Comparison
Technical Chart
Corporate Actions
Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Name Change
Split Of Face Value
Event Calendar
Other Markets
ADR Prices
FII Investments
MF Investments
Forex Details
World Indices
GDR Prices
Equity
Derivative
Currency
Commodity
Mutual Fund
IPO
Price Analysis
Volume Analysis
News Analysis
Market Option
Other Option
Company Information
Gainers & Losers
52 Week High Low
News Highs and Low
Advances & Declines
Home
Market Info
Corporate Information
Company Snapshot
Company Snapshot
BSE
Marksans Pharma Ltd
BSE Code
524404
ISIN Demat
INE750C01026
Book Value (₹)
25.68
NSE Symbol
MARKSANS
Div & Yield %
0.3
Market Cap (
₹
Cr.)
7,531.58
P/E *
63.44
EPS *
2.62
Face Value (₹)
1
* Profit to Earning Ratio
* Earning Per Share
Stock Price Details
Last Price (₹)
168.55
Change
-1.35 (-0.81%)
Best Buy (₹)
0.00
Best Sell (₹)
0.00
Today's Range
163.50 - 169.50
52-Week Range
70.20 - 185.40
Beta (1 Year)
1.03
Chart
1 Day
|
5 Day
|
3 Month
|
1 Year
|
5 Year
Corporate Announcements
Marksans Pharma's Goa unit concludes USFDA inspection with observations
Marksans Pharma declines after US FDA issues Form 483 with 5 observations to Goan plant
Marksans Pharma Ltd - Marksans Pharma Limited - Press Release
Marksans Pharma Ltd - Marksans Pharma Limited - Press Release
Dhani Services Ltd leads gainers in 'A' group
Marksans Pharma Ltd - Marksans Pharma Limited - Other General Purpose
Marksans Pharma Ltd - Marksans Pharma Limited - Loss of Share Certificates
Marksans Pharma Ltd - Marksans Pharma Limited - Loss of Share Certificates
Marksans Pharma Ltd - Marksans Pharma Limited - Loss of Share Certificates
Marksans Pharma Ltd - Marksans Pharma Limited - Loss of Share Certificates
Corporate Details
Incorporation Year :
1992
Chairman :
Mark Saldanha
Ownership Group :
Indian Private
Sector :
Pharmaceuticals
Industry :
Pharmaceuticals - Indian - Formulations
Registered Office :
Marksans Pharma Ltd
11th Flr GRANDEUR Oshiwara,
Veera Desai Extn Rd Andheri(W),
Mumbai,
Maharashtra - 400053,
Phone : 91-22-40012000,
Fax : 91-22-40012011
E-Mail :
companysecretary@marksanspharma.com ; info@marksan
URL :
http://www.marksanspharma.com
Investor Returns
Period
Date
Price
Returns (%)
1Week
26-Apr-2024
172.20
-3.48
1Month
03-Apr-2024
162.00
2.59
3Month
05-Feb-2024
148.50
11.92
6Month
03-Nov-2023
112.65
47.54
1Year
03-May-2023
80.65
106.08
Mutual Funds Holding
Scheme Name
% Holding
Market Value
Quant Small Cap Fund
1.11
192.02
UTI-Aggressive Hybrid Fund
0.71
37.82
UTI-Large & Mid Cap Fund
0.71
19.70
UTI-Retirement Fund
0.41
17.79
UTI-Healthcare Fund
1.33
12.63
Peerset : Pharmaceuticals - Indian - Formulations
Company
Last Price (₹)
Change (%)
52Week High (₹)
52Week Low (₹)
Market Cap (₹ Cr.)
Torrent Pharmaceuticals Ltd
2,732.60
2.20
2,782.00
1,599.00
92,479.45
Ajanta Pharma Ltd
2,377.00
6.44
2,531.95
1,240.55
29,930.39
Gland Pharma Ltd
1,683.80
-2.16
2,195.75
861.50
27,733.96
ERIS Lifesciences Ltd
867.05
-2.68
971.00
605.20
11,796.00
Caplin Point Laboratories Ltd
1,298.80
-2.43
1,617.80
673.10
9,863.31
Index Details
BSE HC, BSE SmallCap